FDA Signs Off On “Authorized” Generics; Mylan Expected To Sue
Executive Summary
Congress, not FDA, has the responsibility to stop the use of "authorized" generic agreements, the agency said in denying petitions filed by the generic drug industry
You may also be interested in...
Congress, Not Court, Is Place To Change "Authorized" Generic Policy, Judge Says
Congress is a better venue for changing FDA's regulation of "authorized" or brand generics, a D.C. Circuit Court of Appeals judge suggests. Teva faces skepticism during oral arguments in its challenge of the agency's refusal to block authorized generics during an ANDA first-filer's 180-day exclusivity.
“Authorized” Generics Are “Legitimate Business Strategy,” Pfizer Says
Pfizer views "authorized" generics as a sound business strategy following a drug's patent expiration, Senior Corporate Counsel Jeffrey Chasnow said during a Drug & Device Dialogue audio conference Oct. 7
“Authorized” Generics Are “Legitimate Business Strategy,” Pfizer Says
Pfizer views "authorized" generics as a sound business strategy following a drug's patent expiration, Senior Corporate Counsel Jeffrey Chasnow said during a Drug & Device Dialogue audio conference Oct. 7